Summary
To assess the role of fasting plasma non-esterified fatty acids (NEFA) in the development of non-insulin-dependent diabetes mellitus (NIDDM), data were analysed from annual examinations of 190 non-diabetic Pima Indians. Glucose tolerance was measured by a 75-g oral glucose tolerance test, insulin action by a euglycaemic hyperinsulinaemic (40 mU · m−2 · min−1) clamp and in vitro lipolysis using isolated abdominal fat cells. After a mean follow-up period of 4.0±2.4 years (mean ± SD), 47 subjects developed NIDDM. Risk factors for NIDDM were estimated by proportional-hazards analysis and risk ratios (RR) with 95% confidence intervals (95% CI) calculated at the 90th and 10th percentile of the predictor variables. A large average fat-cell volume was predictive of NIDDM (RR=2.4; 95% CI=1.2–4.8) independent of age, sex, percent body fat and body fat distribution. A high fasting plasma NEFA concentration was also a risk factor for NIDDM (RR=2.3; 95% CI=1.1–4.7) independent of sex, percent body fat, waist/thigh ratio, insulin-mediated glucose uptake and fasting triglyceride concentration. We conclude that large fat cells and the resulting increased plasma NEFA concentrations are risk factors for the development of NIDDM.
Article PDF
Similar content being viewed by others
Abbreviations
- NEFA:
-
Non-esterified fatty acids
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- CI:
-
confidence interval
- RR:
-
risk ratio
References
Lillioja S, Mott D, Spraul M et al. (1993) Insulin resistance as precursor of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988–1992
Randle PJ, Hales CN, Garland PB, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785–789
Ashour D, Honsford RG (1983) Effect of free acids and ketones on the activity of pyruvate dehydrogenase in skeletal muscle mitochondria. Biochem J 214: 725–736
Lillioja S, Bogardus C, Mott D, Kennedy LA, Knowler WC, Howard BV (1985) Relationship between insulin mediated glucose disposal and lipid metabolism in man. J Clin Invest 75: 1106–1115
Ferrannini E, Barrett EJ, Bevilacqua S, De Fronzo RA (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72: 1737–1747
Bonadonna RC, Zych K, Boni C, Ferrannini E, De Fronzo RA (1989) Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257: E49–E56
Balasse EO, Neef MA (1973) Influence of nicotinic acid on the rates of turnover and oxidation of plasma glucose in man. Metabolism 22: 1193–1204
Gomez F, Jéquier E, Chabot V, Buber V, Felber JP (1972) Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose metabolism. Metabolism 21: 381–391
Ebeling P, Koivisto VA (1994) Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 37: 202–209
Felber JP, Haesler E, Jéquier E (1993) Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 1221–1229
Diabetes Mellitus (1985) Report of a WHO study group. World Health Organization pp 9–17
Goldman RF, Bushkirk ER (1961) Body volume measurement by underwater weighing: description of a method. In: Brozek J, Herschel A (eds) Techniques for measuring body composition: proceedings of a conference. Quartermaster Research and Engineers Center, Natick, Mass. January 22–23, 1959 Washington D.C. National Research Council, pp 78–89
Siri WE (1961) Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Herschel A (eds) Techniques for measuring body composition: proceedings of a conference: Quartermaster Research and Engineers Center, Natick, Mass. January 22–23, 1959 Washington D.C. National Research Council, pp 223–244
Lillioja S, Mott D, Howard BV, Bennet PH et al. (1988) Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217–1225
Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from Pima Indians. Diabetes Metab Rev 4: 517–540
Foley J, Thuillez P, Lillioja S, Zawazki J, Bogardus C (1986) Insulin sensitivity in adipocytes from subjects with varying degree of glucose tolerance. Am J Physiol 251: E306–E310
Kashiwagi A, Verso MA, Andrews JA, Vasquez B, Reaven GM, Foley J (1983) In vitro insulin resistance of human adipocytes isolated from subjects with non-insulin dependent diabetes mellitus. J Clin Invest 72: 1246–1254
Gliemann J (1967) Assay of insulin-like activity by the isolated fat method. 1. Factors influencing the response to crystalline insulin. Diabetologia 3: 382–388
Herbert V, Lan K, Gottlieb CW, Bleicher SI (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39: 1157–1167
Miles J, Glassoch R, Aiken J, Gerich J, Haymond A (1983) A microfluorimetric method for the determination of free fatty acids. J Lipid Res 24: 95–99
Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476–482
Cox DR (1972) Regression model and life-tables. J Royal Statistic Soc 34: 187–220
Lillioja S, Foley J, Bogardus C, Mott D, Howard BV (1986) Free fatty acid metabolism and obesity in man: in vivo and in vitro comparisons. Metabolism 35: 505–514
Golay A, Felber JP, Jéquier E, De Fronzo RA, Ferrannini E (1988) Metabolic basis of obesity and non-insulin dependent diabetes mellitus. Diabetes Metab Rev 4: 727–747
Kida Y, Esposito-Del Puente A, Bogardus C, Mott D (1990) Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 85: 476–481
Munger R, Temler E, Jallut D, Haesler E, Felber JP (1993) Correlations of glycogen synthase and phosphorylase activities with glycogen concentration in human muscle biopsies. Evidence for a double feed-back mechanism regulating glycogen synthesis and breakdown. Metabolism 42: 36–43
Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438–2446
Kelley DE, Mokan M, Simoneau JA, Mandarino L (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92: 91–98
Opara EC, Garfinkel M, Hubbard VS, Burch WM, Akwari OE (1994) Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. Am J Physiol 266: E635–E639
Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870–876
Crespin SR, Greenough WB, Steinberg D (1969) Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest 48: 1934–1943
Campillo JE, Valdivia MM, Rodriguez E, Osorio C (1979) Effect of oleic and octanoic acids on glucose-induced insulin release in vitro. Diabete Metab 5: 183–187
Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) Β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-Β-cell relationships. Proc Natl Acad Sci 91: 10878–10882
Svedberg J, Björntorp P, Smith U, Lönnroth P (1992) Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes from lean and obese rats. Diabetes 41: 294–298
Williamson JR, Browning T, Sholz R (1969) Control mechanisms of gluconeogenesis and ketogenesis. 1. Effects of oleate on gluconeogenesis in perfused rat liver. J Biol Chem 224: 4607–4616
Foley J (1992) Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15: 773–784
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paolisso, G., Tataranni, P.A., Foley, J.E. et al. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38, 1213–1217 (1995). https://doi.org/10.1007/BF00422371
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422371